Pathways of Tennessee Inc Substance Abuse Treatment Division
-
Services:
- Treatment for other addiction disorder
- Treatment for gambling disorder
- Motivational interviewing
- Relapse prevention
- Anger management
- Trauma-related counseling
- Telemedicine/telehealth therapy
- Cognitive behavioral therapy
- Substance use disorder counseling
- Screening for mental disorders
- Comprehensive mental health assessment
- Interim services for clients
- Screening for tobacco use
- Screening for substance use
- Comprehensive substance use assessment
- Mental health services
- Case management service
- Social skills development
- Transportation assistance
- Suicide prevention services
- Smoking not permitted
- Drug or alcohol urine screening
- Metabolic syndrome monitoring
- Breathalyzer or blood alcohol testing
- STD testing
- TB screening
- Children/Adolescents
- Sign language services for the deaf and hard of hearing
- Relapse prevention with naltrexone
- Buprenorphine maintenance
- Buprenorphine detoxification
- Maintenance service with medically supervised withdrawal after stabilization
- Prescribes buprenorphine
- Does not treat opioid use disorders
- Prescribes naltrexone
- Hepatitis education, counseling, or support
- Family counseling
- Marital/couples counseling
- Group counseling
- Health education services other than HIV/AIDS or hepatitis
- Substance use disorder education
- Smoking/vaping/tobacco cessation counseling
- Individual counseling
- Naltrexone (extended-release, injectable)
- Buprenorphine without naloxone
- Disulfiram
- Medication for mental disorders
- Acamprosate (CampralĀ®)
- Nicotine replacement
- Naltrexone (oral)
- Buprenorphine with naloxone
- Non-nicotine smoking/tobacco cessation
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Clients with co-occurring mental and substance use disorders
- Recovery coach
- Mentoring/peer support
- Employment counseling or training
- Housing services
- Discharge Planning
- Outcome follow-up after discharge
- Aftercare/continuing care
- Naloxone and overdose education
- SAMHSA funding/block grants
- Medicaid
- Cash or self-payment
- Medicare
- Federal, or any government funding for substance use treatment programs
- Private health insurance
- Federal military insurance (e.g., TRICARE)
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- Intensive outpatient treatment
- Hospital inpatient/24-hour hospital inpatient
- Hospital inpatient detoxification
- Outpatient
- Regular outpatient treatment
- Male
- Female
- In-network prescribing entity
- Vaping not permitted
- Private non-profit organization
- Sliding fee scale (fee is based on income and other factors)
- Payment assistance (check with facility for details)
- State Substance use treatment agency
- The Joint Commission
- State mental health department
- Substance use treatment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Detoxification
- Opioids detoxification
- Medication routinely used during detoxification
- Alcohol Detoxification
- Benzodiazepines Detoxification
- Methamphetamines detoxification
Other Services
Treatment Approaches
Assessment/Pre-treatment
Ancillary Services
Facility Smoking Policy
Testing
Age Groups Accepted
Language Services
Type of Opioid Treatment
Education and Counseling Services
Pharmacotherapies
Opioid Medications used in Treatment
Special Programs/Groups Offered
Recovery Support Services
Transitional Services
Payment/Insurance/Funding Accepted
Type of Alcohol Use Disorder Treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Gender Accepted
External Source of Medications Used for Alcohol Use Disorder Treatment
Facility Vaping Policy
Facility Operation (e.g., Private, Public)
Payment Assistance Available
License/Certification/Accreditation
Type of Care
Detoxification (medical withdrawal) Services